D. Lefranc

554 total citations
15 papers, 319 citations indexed

About

D. Lefranc is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, D. Lefranc has authored 15 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Physiology. Recurrent topics in D. Lefranc's work include Alzheimer's disease research and treatments (3 papers), Multiple Sclerosis Research Studies (3 papers) and Genetic Neurodegenerative Diseases (3 papers). D. Lefranc is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Multiple Sclerosis Research Studies (3 papers) and Genetic Neurodegenerative Diseases (3 papers). D. Lefranc collaborates with scholars based in France, Ivory Coast and Ireland. D. Lefranc's co-authors include Patrick Vermersch, Nicolas Sergeant, A. Wattez, André Delacourte, Jean‐Philippe David, Lionel Prin, Sylvain Dubucquoi, J. de Sèze, Luc Buée and Michel Goedert and has published in prestigious journals such as Neurology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

D. Lefranc

14 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lefranc France 9 182 116 85 55 50 15 319
Tamao Tsukie Japan 11 224 1.2× 184 1.6× 63 0.7× 47 0.9× 44 0.9× 18 375
Guro Berge Norway 11 207 1.1× 72 0.6× 70 0.8× 67 1.2× 34 0.7× 15 341
Jayashree Viswanathan Finland 12 263 1.4× 205 1.8× 102 1.2× 68 1.2× 51 1.0× 23 454
Sandra Barral United States 8 208 1.1× 185 1.6× 26 0.3× 33 0.6× 44 0.9× 13 399
Outi Heinonen Finland 10 242 1.3× 129 1.1× 43 0.5× 25 0.5× 46 0.9× 12 333
Petros Takousis United Kingdom 8 120 0.7× 244 2.1× 96 1.1× 52 0.9× 37 0.7× 13 441
Nina Schultz Sweden 12 169 0.9× 84 0.7× 38 0.4× 133 2.4× 44 0.9× 18 346
Thorsten Pflanzner Germany 8 180 1.0× 136 1.2× 52 0.6× 114 2.1× 45 0.9× 9 416
Susana Carmona Portugal 7 172 0.9× 133 1.1× 65 0.8× 146 2.7× 69 1.4× 18 387
Tomoshi Kakeya Japan 8 144 0.8× 142 1.2× 31 0.4× 65 1.2× 30 0.6× 12 346

Countries citing papers authored by D. Lefranc

Since Specialization
Citations

This map shows the geographic impact of D. Lefranc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lefranc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lefranc more than expected).

Fields of papers citing papers by D. Lefranc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lefranc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lefranc. The network helps show where D. Lefranc may publish in the future.

Co-authorship network of co-authors of D. Lefranc

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lefranc. A scholar is included among the top collaborators of D. Lefranc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lefranc. D. Lefranc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lefranc, D., Luc Humbert, Camille Richeval, et al.. (2016). Intérêt de la biométrologie et des prélèvements surfaciques dans l’évaluation de l’exposition professionnelle aux cytotoxiques en milieu hospitalier. Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement. 77(3). 475–475.
2.
Lee-Chang, Catalina, Alain Duhamel, Magali Toussaint, et al.. (2014). High‐affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 172(7). 1769–1782. 15 indexed citations
4.
Proust-Lemoine, Emmanuelle, Pascale Saugier-Véber, Hervé Lefèbvre, et al.. (2010). Polyendocrinopathies auto-immunes de type 1. Archives de Pédiatrie. 17(6). 597–598. 3 indexed citations
5.
Proust-Lemoine, Emmanuelle, Pascale Saugier-Véber, D. Lefranc, et al.. (2010). Autoimmune Polyendocrine Syndrome Type 1 in North-Western France: <i>AIRE</i> Gene Mutation Specificities and Severe Forms Needing Immunosuppressive Therapies. Hormone Research in Paediatrics. 74(4). 275–284. 28 indexed citations
6.
Girard, Antoine, et al.. (2009). L’intoxication éthylique aiguë à l’hôpital : un enjeu clinique. Étude prospective sur un an en hôpital général. La Revue de Médecine Interne. 30(4). 316–321. 12 indexed citations
7.
Legrand, Fanny, P.Y. Hatron, Sylvain Dubucquoi, et al.. (2009). Imatinib Mesylate dans les syndromes hyperéosinophiliques associés ou non au réarrangement FIP1L1-PDGFRA. La Revue de Médecine Interne. 30. S355–S356. 1 indexed citations
8.
Zéphir, Hélène, D. Lefranc, Sylvain Dubucquoi, et al.. (2009). Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. Multiple Sclerosis Journal. 15(5). 593–600. 9 indexed citations
9.
Sèze, J. de, Sylvain Dubucquoi, A.L. Fauchais, et al.. (2003). α-Fodrin autoantibodies in the differential diagnosis of MS and Sjogren syndrome. Neurology. 61(2). 268–269. 15 indexed citations
10.
Dubucquoi, Sylvain, J. de Sèze, D. Lefranc, et al.. (2002). Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome. Journal of Neuroimmunology. 129(1-2). 232–236. 3 indexed citations
11.
Sèze, J. de, et al.. (2001). IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. Journal of Neuroimmunology. 117(1-2). 149–155. 31 indexed citations
12.
Lefranc, D., Sylvain Dubucquoi, Lionel Alméras, et al.. (2001). Molecular Analysis of Endogenous Retrovirus HRES-1: Identification of Frameshift Mutations in Region Encoding Putative 28-kDa Autoantigen. Biochemical and Biophysical Research Communications. 283(2). 437–444. 4 indexed citations
13.
Molina, Laurence, J. Touchon, D. Lefranc, et al.. (1999). Tau and apo E in CSF. Neuroreport. 10(17). 3491–3495. 45 indexed citations
14.
Sergeant, Nicolas, Jean‐Philippe David, D. Lefranc, et al.. (1997). Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Letters. 412(3). 578–582. 92 indexed citations
15.
Sergeant, Nicolas, Jean‐Philippe David, Michel Goedert, et al.. (1997). Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications. Journal of Neurochemistry. 69(2). 834–844. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026